Collaborating Investigator: Roland Herzog, PhD Affiliation: Riley Children’s Foundation Professor of Immunology, Indiana University   Funding Source: NIH Funding: Number: P01HL160472  Project Period: 02/05/22-01/31/27   Significance The X-linked bleeding disorder Hemophilia A is caused by a deficiency in the clotting protein factor VIII (FVIII), and FVIII gene therapy thus provides a promising strategy for disease treatment....

Collaborating Investigator: Armando Villalta, PhD Affiliation: Assistant Professor, Physiology & Biophysics; University of California, Irvine Funding Source: NIHGrant Number: 2R01NS120060  Project Period: 09/30/20-08/31/25 Significance Duchenne muscular dystrophy (DMD) is caused by loss-of-function mutations in the dystrophin gene that lead to widespread muscle degeneration, and the disease is therefore frequently treated via dystrophin...

Collaborating Investigator: Dino Di Carlo, PhD Affiliation: Cleveland ClinicDirector, Lerner Research Institute, Cleveland Clinic  Funding Source: NSFGrant Number: 2149551   Project Period: 09/15/22-08/31/25 Significance The Di Carlo Lab leverages microfluidics, microfabrication, and nanotechnologies to develop interfaces with cells and molecules for applications in disease diagnosis, therapeutic discovery, tissue regeneration, and...

...

...

...

...

...

...

...